The impact of microbial keratitis on quality of life in Uganda.

Simon ArungaGeoffrey WiafeEsmael HabtamuJohn OnyangoStephen GichuhiAstrid LeckDavid MacleodVictor HuMatthew Burton

Published in: BMJ open ophthalmology (2019)

MK severely reduces QoL in the acute phase. With treatment and healing, QoL subsequently improves. Despite this improvement, QoL of someone affected by MK (even with normal vision) remains lower than unaffected controls.

Keyphrases

microbial community
replacement therapy